Oxford Research Suggests Anti-Viral Treatment on Children Causes More Harm Than Good in Defense to the Swine Flu (HINI Virus)

Share Article

A new study by Oxford researchers published in the British Medical Journal casts doubt on the use of anti-viral treatments as a viable method of treatment for children. Byron J. Richards, Board-Certified Clinical Nutritionist and founder of Wellness Resources http://www.wellnessresources.com , says the study calls to question the wisdom in the United States' and Great Britain's plan to use antiviral drugs as a first line of defense against the Swine Flu, especially in at risk groups such as young children.

Treating flu-stricken children with anti-viral medication including Tamiflu and Relenza could do more harm than good, a study from the University of Oxford warns. Byron J. Richards CCN summarizes the study as a systematic review and meta-analysis on the use of anti-viral drugs, Tamiflu and Relenza, on children under 12 to determine their safety and effectiveness in treating children with flu and the ability of these drugs to prevent children from getting the flu. According to the study, the drugs were found to reduce the duration of the flu by a day, yet not to reduce the complications of the flu such as fewer asthma problems in children with existing asthma or the need to use antibiotics to treat secondary ear infections arising as part of the flu illness process.

This data alone suggests any benefits are very weak and offer far less protection than basic nutrients that have no adverse effects such as vitamin D, vitamin C, zinc, and acidophilus. Richards, questions why "For such little benefit, public health officials are willing to expose millions of children to potentially serious and life-threatening medical 'prevention' treatment."

Health experts have for several years, questioned the misuse and effectiveness of Tamiflu Back in 2006, the Food and Drug Administration (FDA) admitted they were concerned that when or if the use of this drug increases in the U.S, there may be increasing cases of adverse consequence in the U.S. The FDA added a warning label to Tamiflu, based on numerous reports of serious adverse side effects including panic attacks, delusions, delirium, convulsions, depression, loss of consciousness, and even suicide. The FDA warning states, "People with the flu, particularly children, may be at an increased risk of self-injury and confusion shortly after taking Tamiflu and should be closely monitored for signs of unusual behavior."

"That is a very weak warning considering that three normal children jumped/fell to their death after taking the drug - one even leaving a suicide note. Other children were struck with psychosis, delusions, and paranoia - all in formerly normal children," continued Richards, "the Oxford research, points out that the drugs have very little value in the first place and carry serious health risks for an unacceptably large percentage of children."

Richards believes part of the reason for the use of Tamiflu is the massive government stockpiles of these drugs that resulted from the preparation for the bird flu. During 2006 the U.S. government received 20 million doses of Tamiflu at a cost of 2 billion dollars. The product has a three year shelf life and is nearing its expiration date.

Byron J. Richards, Founder/Director of Wellness Resources, Inc., http://www.wellnessresources.com is a Board-Certified Clinical Nutritionist and a world renowned natural health expert. He has been a charter professional member of the International and American Associations of Clinical Nutritionists (IAACN) since 1991. Richards' 23 years of in depth experience on the front lines of clinical nutrition has helped thousands of individuals with complex health situations.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Andrew Salmen
Visit website